Associations of GDF-15 and GDF-15/adiponectin ratio with odds of type 2 diabetes in the Chinese population

被引:9
|
作者
Wu, Xiaoying [1 ]
Xuan, Wenting [2 ]
You, Lili [1 ]
Lian, Hong [1 ]
Li, Feng [1 ]
Zhang, Xiaoyun [1 ]
Chen, Qingyu [3 ]
Sun, Kan [1 ]
Chen, Chaogang [1 ]
Xu, Mingtong [1 ]
Li, Yan [1 ]
Yan, Li [1 ]
Zhang, Xiuwei [2 ]
Ren, Meng [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, 107 Yanjiang West Rd, Guangzhou 510120, Peoples R China
[2] Dongguan Peoples Hosp, Dept Endocrinol, 3 South,Xinguyongwan Rd, Dongguan 523059, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Boji Healthcare Ctr, 107 Yanjiang West Rd, Guangzhou 510120, Peoples R China
关键词
Growth differentiation factor-15; Adiponectin; GDF-15; adiponectin; Type; 2; diabetes;
D O I
10.1007/s12020-021-02632-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose We elucidate the effect of Growth differentiation factor-15(GDF-15)/adiponectin ratio in improving the assessment value for odds of type 2 diabetes. Methods Cross-sectional design. A total of 405 participants (135 patients with newly diagnosed type 2 diabetes, 135 age- and sex-matched participants with prediabetes, and 135 healthy controls) were collected from Guangzhou and Dongguan, China. The serum GDF-15 and adiponectin levels were measured by ELISA and latex-enhanced immunoturbidimetry. Logistic regression analysis and restricted cubic splines were used to evaluate the associations between diabetes and the indicators. Results The low level of adiponectin and high GDF-15/adiponectin ratio were significantly associated with increased odds of type 2 diabetes, but not for GDF-15. Three clusters were identified based on the K-means clustering analysis. Compared to the lowest quartiles of adiponectin, the OR and 95% CI of the highest adiponectin with type 2 diabetes was 0.24 (0.07-0.74, p trend = 0.004) after adjusting for sex, age, BMI, and DBP only in cluster 1. After adjusting for confounding factors, subjects with the highest GDF-15/adiponectin ratio quartiles had 3.9 times (OR = 3.85, 95% CI = 0.76-24.25) and 3.8 times (OR = 3.80, 95% CI = 1.02-14.68) higher odds of type 2 diabetes in cluster 2 and cluster 3, respectively. The association between the GDF-15/adiponectin ratio and type 2 diabetes was attenuated, but still remarkable (OR = 3.18, 95% CI = 1.11-10.18), in cluster 1. Conclusions Higher GDF-15/adiponectin ratio is independently associated with increased odds of type 2 diabetes for all study populations, suggesting that the GDF-15/adiponectin ratio may be a better indicator of type 2 diabetes.
引用
收藏
页码:423 / 436
页数:14
相关论文
共 50 条
  • [1] Associations of GDF-15 and GDF-15/adiponectin ratio with odds of type 2 diabetes in the Chinese population
    Xiaoying Wu
    Wenting Xuan
    Lili You
    Hong Lian
    Feng Li
    Xiaoyun Zhang
    Qingyu Chen
    Kan Sun
    Chaogang Chen
    Mingtong Xu
    Yan Li
    Li Yan
    Xiuwei Zhang
    Meng Ren
    Endocrine, 2021, 72 : 423 - 436
  • [3] Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort
    Welsh, Paul
    Kimenai, Dorien M.
    Marioni, Riccardo E.
    Hayward, Caroline
    Campbell, Archie
    Porteous, David
    Mills, Nicholas L.
    O'Rahilly, Stephen
    Sattar, Naveed
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (11) : 1820 - 1829
  • [4] Development of novel ELISAs for total GDF-15 and H-specific GDF-15
    Kalra, B.
    Parekh, H.
    Patel, A. S.
    Mistry, S.
    Hyvonen, M.
    Kumar, A.
    CLINICAL CHEMISTRY, 2024, 70 : I11 - I11
  • [5] GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes
    Pavo, Noemi
    Wurm, Raphael
    Neuhold, Stephanie
    Adlbrecht, Christopher
    Vila, Greisa
    Strunk, Guido
    Clodi, Martin
    Resl, Michael
    Brath, Helmut
    Prager, Rudolf
    Luger, Anton
    Pacher, Richard
    Huelsmann, Martin
    CLINICAL CHEMISTRY, 2016, 62 (12) : 1612 - 1620
  • [6] GDF-15 levels and atherosclerosis
    Chen, Jingfei
    Luo, Fei
    Fang, Zhenfei
    Zhang, Weishe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 257 : 36 - 36
  • [7] Metformin and Growth Differentiation Factor 15 (GDF-15) in Youth with Type 2 Diabetes
    Matta, Samantha
    Cravalho, Celeste K.
    Villalobos-Perez, Alfredo
    Mabundo, Lilian
    Sharma, Vandhna R.
    Walter, Mary
    Dawson, Joshua M.
    Zenno, Anna
    Courville, Amber B.
    Haymond, Morey W.
    Chung, Stephanie T.
    DIABETES, 2021, 70
  • [8] GDF-15 as a Biomarker in Cardiovascular Disease
    May, Bruna Miers
    Pimentel, Mauricio
    Zimerman, Leandro Ioschpe
    Rohde, Luis Eduardo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (03) : 494 - 500
  • [9] Macrophages as a Source and Target of GDF-15
    Silva-Bermudez, Lina Susana
    Klueter, Harald
    Kzhyshkowska, Julia G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [10] Influence of the matrix type over the concentration of GDF-15
    Rivera-Caravaca, Jose Miguel
    Vilchez, Juan Antonio
    Rodriguez-Rojas, Carlos
    Albadalejo-Oton, Maria Dolores
    Gil-Perez, Pablo
    Lopez-Garcia, Cecilia
    Veliz-Martinez, Andrea
    Roldan, Vanessa
    Marin, Francisco
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (08) : 1402 - 1404